32 related articles for article (PubMed ID: 32633087)
1. Dermatoscopy of pigmentary changes in systemic sclerosis.
Sushama S; Bansal S; Poonia K
Australas J Dermatol; 2024 May; ():. PubMed ID: 38814106
[No Abstract] [Full Text] [Related]
2. Association between endothelin-1 and systemic lupus erythematosus: insights from a case-control study.
Li R; Yang C; Tang YY; Wang DC; Xu WD; Huang AF
Sci Rep; 2023 Sep; 13(1):15970. PubMed ID: 37749230
[TBL] [Abstract][Full Text] [Related]
3. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
[TBL] [Abstract][Full Text] [Related]
4. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M
Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.
Lemaire R; Farina G; Bayle J; Dimarzio M; Pendergrass SA; Milano A; Perbal B; Whitfield ML; Lafyatis R
J Invest Dermatol; 2010 Jun; 130(6):1514-23. PubMed ID: 20182440
[TBL] [Abstract][Full Text] [Related]
6. Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis.
Tabata H; Hara N; Otsuka S; Yamakage A; Yamazaki S; Koibuchi N
Int J Dermatol; 2000 Dec; 39(12):899-902. PubMed ID: 11168657
[TBL] [Abstract][Full Text] [Related]
7. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes.
Henrot P; Pain C; Taïeb A; Truchetet ME; Cario M
Pigment Cell Melanoma Res; 2020 Nov; 33(6):895-898. PubMed ID: 32633087
[TBL] [Abstract][Full Text] [Related]
9. CCN proteins as potential actionable targets in scleroderma.
Henrot P; Truchetet ME; Fisher G; Taïeb A; Cario M
Exp Dermatol; 2019 Jan; 28(1):11-18. PubMed ID: 30329180
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Roles of CCN3 Protein in Immune-Related Diseases.
Peng L; Wei Y; Shao Y; Li Y; Liu N; Duan L
Mediators Inflamm; 2021; 2021():5576059. PubMed ID: 34393649
[TBL] [Abstract][Full Text] [Related]
11. Precise role of dermal fibroblasts on melanocyte pigmentation.
Wang Y; Viennet C; Robin S; Berthon JY; He L; Humbert P
J Dermatol Sci; 2017 Nov; 88(2):159-166. PubMed ID: 28711237
[TBL] [Abstract][Full Text] [Related]
12. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging.
Van Neste D; Tobin DJ
Micron; 2004; 35(3):193-200. PubMed ID: 15036274
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
